213 related articles for article (PubMed ID: 18637124)
21. [Biochemical and immunological findings of multiple myeloma].
Asaoku H
Nihon Rinsho; 2007 Dec; 65(12):2256-60. PubMed ID: 18069270
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic value of some biochemical and immunologic factors in the management of multiple myeloma].
Abdulkadyrov KM; Stel'mashenko LV; Bessmel'tsev SS; Lubo-Lesnichenko IF; Sel'tser AV; Rozanova OE; Gubarenko NK; Bubnova LN; Mnuskina MM; Zhuchikhina AA; Blinov MN; Gritskevich NL
Vopr Onkol; 1998; 44(3):304-9. PubMed ID: 9695777
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of the serum phosphorus level and its relationship with other prognostic factors in multiple myeloma.
Umeda M; Okuda S; Izumi H; Nagase D; Fujimoto Y; Sugasawa Y; Arai C; Natori K; Katoh M; Kuraishi Y
Ann Hematol; 2006 Jul; 85(7):469-73. PubMed ID: 16528526
[TBL] [Abstract][Full Text] [Related]
24. Changes in quality-of-life and psychosocial adjustment among multiple myeloma patients treated with high-dose melphalan and autologous stem cell transplantation.
Sherman AC; Simonton S; Latif U; Plante TG; Anaissie EJ
Biol Blood Marrow Transplant; 2009 Jan; 15(1):12-20. PubMed ID: 19135938
[TBL] [Abstract][Full Text] [Related]
25. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
Scudla V; Budíková M; Fischerová E; Zadrazil J; Indrák K
Acta Univ Palacki Olomuc Fac Med; 1991; 130():201-12. PubMed ID: 1838869
[TBL] [Abstract][Full Text] [Related]
26. Evaluating quality of life and pulmonary function of long-term survivors of non-small cell lung cancer treated with radical or postoperative radiotherapy.
Ozturk A; Sarihan S; Ercan I; Karadag M
Am J Clin Oncol; 2009 Feb; 32(1):65-72. PubMed ID: 19194128
[TBL] [Abstract][Full Text] [Related]
27. Psychosocial adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation.
Sherman AC; Simonton S; Latif U; Spohn R; Tricot G
Bone Marrow Transplant; 2004 May; 33(9):955-62. PubMed ID: 15034542
[TBL] [Abstract][Full Text] [Related]
28. Staging systems and prognostic factors as a guide to therapeutic decisions in multiple myeloma.
Kyrtsonis MC; Maltezas D; Tzenou T; Koulieris E; Bradwell AR
Semin Hematol; 2009 Apr; 46(2):110-7. PubMed ID: 19389494
[TBL] [Abstract][Full Text] [Related]
29. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
[TBL] [Abstract][Full Text] [Related]
30. [Clinical features and status in multiple myeloma].
Sawamura M; Murakami H; Ogawara H; Tsuchiya J
Rinsho Ketsueki; 1993 Apr; 34(4):444-9. PubMed ID: 8510331
[TBL] [Abstract][Full Text] [Related]
31. Treatment of pathologic fracture and surgical value of prognostic factors in multiple myeloma.
Takei T; Coles M
Int Surg; 1996; 81(4):403-6. PubMed ID: 9127806
[TBL] [Abstract][Full Text] [Related]
32. Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor.
Vela-Ojeda J; García-Ruiz Esparza MA; Padilla-González Y; Sánchez-Cortes E; García-Chávez J; Montiel-Cervantes L; Reyes-Maldonado E; Majluf-Cruz A; Mayani H
Ann Hematol; 2009 Jan; 88(1):59-66. PubMed ID: 18648809
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with lower quality of life among patients receiving palliative care.
Chui YY; Kuan HY; Fu IC; Liu RK; Sham MK; Lau KS
J Adv Nurs; 2009 Sep; 65(9):1860-71. PubMed ID: 19694849
[TBL] [Abstract][Full Text] [Related]
34. Quality-of-life assessment in patients with pemphigus using a minimum set of evaluation tools.
Paradisi A; Sampogna F; Di Pietro C; Cianchini G; Didona B; Ferri R; Abeni D; Tabolli S
J Am Acad Dermatol; 2009 Feb; 60(2):261-9. PubMed ID: 19004524
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors in multiple myeloma].
Pick AI; Tamir R; Vana D; Duczyminer-Kahana M; Weiss H; Lurie H; Dawidowich J; Meyerson E; Gelernter I
Harefuah; 1990 Apr; 118(8):437-42. PubMed ID: 2358224
[TBL] [Abstract][Full Text] [Related]
36. Emotional well-being does not predict survival in head and neck cancer patients: a Radiation Therapy Oncology Group study.
Coyne JC; Pajak TF; Harris J; Konski A; Movsas B; Ang K; Watkins Bruner D;
Cancer; 2007 Dec; 110(11):2568-75. PubMed ID: 17955501
[TBL] [Abstract][Full Text] [Related]
37. Fatigue as a major predictor of quality of life in women with autoimmune liver disease: the case of primary biliary cirrhosis.
Sogolow ED; Lasker JN; Short LM
Womens Health Issues; 2008; 18(4):336-42. PubMed ID: 18420421
[TBL] [Abstract][Full Text] [Related]
38. The need for psychosocial support and its determinants in a sample of patients undergoing radiooncological treatment of cancer.
Brix C; Schleussner C; Füller J; Roehrig B; Wendt TG; Strauss B
J Psychosom Res; 2008 Dec; 65(6):541-8. PubMed ID: 19027442
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma.
Kyrtsonis MC; Vassilakopoulos TP; Kafasi N; Sachanas S; Tzenou T; Papadogiannis A; Galanis Z; Kalpadakis C; Dimou M; Kyriakou E; Angelopoulou MK; Dimopoulou MN; Siakantaris MP; Dimitriadou EM; Kokoris SI; Panayiotidis P; Pangalis GA
Br J Haematol; 2007 May; 137(3):240-3. PubMed ID: 17408464
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and prognostic characteristics of CD33-positive multiple myeloma.
Sahara N; Ohnishi K; Ono T; Sugimoto Y; Kobayashi M; Takeshita K; Shigeno K; Nakamura S; Naito K; Tamashima S; Nara K; Tobita T; Takeshita A; Ohno R
Eur J Haematol; 2006 Jul; 77(1):14-8. PubMed ID: 16827882
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
